Brian G. Drazba
2022 - MEI Pharma
In 2022, Brian G. Drazba earned a total compensation of $879.7K as Chief Financial Officer at MEI Pharma, a 20% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $106,020 |
|---|---|
| Option Awards | $359,500 |
| Salary | $414,140 |
| Total | $879,660 |
Drazba received $414.1K in salary, accounting for 47% of the total pay in 2022.
Drazba also received $106K in non-equity incentive plan and $359.5K in option awards.
Rankings
In 2022, Brian G. Drazba's compensation ranked 3,304th out of 5,736 executives tracked by ExecPay. In other words, Drazba earned more than 42.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,304 out of 5,736 | 42nd |
Division Manufacturing | 1,865 out of 3,125 | 40th |
Major group Chemicals And Allied Products | 887 out of 1,416 | 37th |
Industry group Drugs | 830 out of 1,317 | 37th |
Industry Pharmaceutical Preparations | 604 out of 963 | 37th |
Source: SEC filing on October 27, 2022.
Drazba's colleagues
We found three more compensation records of executives who worked with Brian G. Drazba at MEI Pharma in 2022.